Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,997,000 | 12,886,000 | 6,746,000 | 10,051,000 | 11,631,000 |
| Marketable Securities | 1,411,000 | 11,089,000 | 12,168,000 | 10,734,000 | 12,721,000 |
| Receivables | 4,892,000 | 3,913,000 | 3,194,000 | 3,907,000 | 3,582,000 |
| Inventories | 1,683,000 | 1,008,000 | 1,052,000 | 986,000 | 922,000 |
| TOTAL | $15,996,000 | $30,926,000 | $24,643,000 | $26,950,000 | $30,296,000 |
| Non-Current Assets | |||||
| PPE Net | 4,967,000 | 4,810,000 | 4,653,000 | 4,564,000 | 4,502,000 |
| Investments And Advances | 502,000 | 2,074,000 | 2,276,000 | 3,529,000 | 1,488,000 |
| Intangibles | 41,234,000 | 17,056,000 | 17,342,000 | 17,619,000 | 17,903,000 |
| Other Non-Current Assets | 5,708,000 | 6,012,000 | 7,020,000 | 7,079,000 | 7,438,000 |
| TOTAL | $52,411,000 | $29,952,000 | $31,291,000 | $32,791,000 | $31,331,000 |
| Total Assets | $68,407,000 | $60,878,000 | $55,934,000 | $59,741,000 | $61,627,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,757,000 | 1,498,000 | 2,999,000 | 1,999,000 | 2,499,000 |
| Accounts payable and accrued liabilities | 844,000 | 527,000 | 532,000 | 590,000 | 713,000 |
| Accrued Expenses | 3,460,000 | 3,343,000 | 3,337,000 | 3,457,000 | 3,473,000 |
| TOTAL | $11,397,000 | $9,509,000 | $10,564,000 | $8,879,000 | $9,759,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,859,000 | 28,878,000 | 22,121,000 | 22,098,000 | 23,103,000 |
| Other Non-Current Liabilities | 5,023,000 | 5,027,000 | 5,114,000 | 6,598,000 | 6,122,000 |
| TOTAL | $38,789,000 | $33,898,000 | $27,228,000 | $28,683,000 | $29,218,000 |
| Total Liabilities | $50,186,000 | $43,407,000 | $37,792,000 | $37,562,000 | $38,977,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,256,593 | 1,253,528 | 1,253,724 | 1,254,373 | 1,263,637 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 14,381,000 | 13,709,000 | 14,445,000 | 18,709,000 | 19,388,000 |
| Other shareholders' equity | -41,000 | 49,000 | 185,000 | 158,000 | 210,000 |
| TOTAL | $18,221,000 | $17,471,000 | $18,142,000 | $22,179,000 | $22,650,000 |
| Total Liabilities And Equity | $68,407,000 | $60,878,000 | $55,934,000 | $59,741,000 | $61,627,000 |